Your browser doesn't support javascript.
loading
Targeting DDR2 enhances tumor response to anti-PD-1 immunotherapy.
Tu, Megan M; Lee, Francis Y F; Jones, Robert T; Kimball, Abigail K; Saravia, Elizabeth; Graziano, Robert F; Coleman, Brianne; Menard, Krista; Yan, Jun; Michaud, Erin; Chang, Han; Abdel-Hafiz, Hany A; Rozhok, Andrii I; Duex, Jason E; Agarwal, Neeraj; Chauca-Diaz, Ana; Johnson, Linda K; Ng, Terry L; Cambier, John C; Clambey, Eric T; Costello, James C; Korman, Alan J; Theodorescu, Dan.
Afiliação
  • Tu MM; Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Lee FYF; Bristol-Myers Squibb, Lawrenceville, NJ, USA.
  • Jones RT; Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Kimball AK; Department of Anesthesiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Saravia E; Bristol-Myers Squibb, Lawrenceville, NJ, USA.
  • Graziano RF; Bristol-Myers Squibb, Lawrenceville, NJ, USA.
  • Coleman B; Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO, USA.
  • Menard K; Bristol-Myers Squibb, Lawrenceville, NJ, USA.
  • Yan J; Bristol-Myers Squibb, Lawrenceville, NJ, USA.
  • Michaud E; Bristol-Myers Squibb, Lawrenceville, NJ, USA.
  • Chang H; Bristol-Myers Squibb, Lawrenceville, NJ, USA.
  • Abdel-Hafiz HA; Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Rozhok AI; Department of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, CO, USA.
  • Duex JE; Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Agarwal N; Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Chauca-Diaz A; Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Johnson LK; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Ng TL; Division of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada.
  • Cambier JC; Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO, USA.
  • Clambey ET; Department of Anesthesiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Costello JC; Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Korman AJ; Bristol-Myers Squibb, Redwood City, CA, USA.
  • Theodorescu D; Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, USA.
Sci Adv ; 5(2): eaav2437, 2019 02.
Article em En | MEDLINE | ID: mdl-30801016
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sistemas de Liberação de Medicamentos / Linfócitos T CD8-Positivos / Receptor de Morte Celular Programada 1 / Dasatinibe / Receptor com Domínio Discoidina 2 / Imunidade Celular / Imunoterapia / Neoplasias Experimentais Limite: Animals Idioma: En Revista: Sci Adv Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sistemas de Liberação de Medicamentos / Linfócitos T CD8-Positivos / Receptor de Morte Celular Programada 1 / Dasatinibe / Receptor com Domínio Discoidina 2 / Imunidade Celular / Imunoterapia / Neoplasias Experimentais Limite: Animals Idioma: En Revista: Sci Adv Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos